pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 718 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
LMN-201
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Lumen Bioscience Inc
0 catalysts
Phase 1
LP-102
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Lpoxy Therapeutics Inc
0 catalysts
Phase 2
LXE-408
Leishmaniasis
$NVSNOVARTIS AG
0 catalysts
pre_registration
← prev
page 10 of 24
next →
131
Pain89
Neurology1
Lagevrio
Lagevrio (molnupiravir)
Coronavirus Disease 2019 (COVID-19)
$MRKMerck & Co., Inc.
0 catalysts
Marketed
Lopimune
Lopinavir + Ritonavir ((lopinavir + ritonavir))
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Cipla USA Inc
0 catalysts
Preclinical
MBP-091
Marburgvirus Infections (Marburg Hemorrhagic Fever)
Mapp Biopharmaceutical Inc
0 catalysts
Phase 1
MBP-134
Ebolavirus Infections (Ebola Hemorrhagic Fever)
Mapp Biopharmaceutical Inc
0 catalysts
Phase 1
MDX-2301
Coronavirus Disease 2019 (COVID-19)
ModeX Therapeutics Inc
0 catalysts
Phase 2
MGD-014
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$MGNXMACROGENICS INC
0 catalysts
Phase 3
MK-1406
Pandemic Influenza
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
MP-1032
Coronavirus Disease 2019 (COVID-19)
MetrioPharm AG
0 catalysts
Phase 1
MRX-8
Acinetobacter Infections
MicuRx Pharmaceuticals Inc
0 catalysts
Phase 2
MVAmBN-396
Eastern Equine Encephalitis
Bavarian Nordic AS
0 catalysts
Phase 2
MVCCOV-1901
Coronavirus Disease 2019 (COVID-19)
Medigen Vaccine Biologics Corp
0 catalysts
Preclinical
Marburg vaccine
Marburgvirus Infections (Marburg Hemorrhagic Fever)
$SNGXSOLIGENIX, INC.
0 catalysts
Phase 1
NAS-150
Idiopathic Pulmonary Fibrosis
New Amsterdam Sciences Inc
0 catalysts
Preclinical
NGoXIM
Gonorrhea
TherapyX Inc
0 catalysts
Phase 3
NP-028
Coronavirus Disease 2019 (COVID-19)
$EBSEmergent BioSolutions Inc.
0 catalysts
Phase 2
NP-213
Novexatin
Onychomycosis (Tinea Unguium)
Novabiotics Ltd
0 catalysts
Phase 2
NTCDM-3
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Destiny Pharma Ltd
0 catalysts
Preclinical
NV-360
Herpes Zoster (Shingles)
$NNVCNANOVIRICIDES, INC.
0 catalysts
Preclinical
NVK-006
Unspecified Infectious Diseases
Nevakar Injectables Inc
0 catalysts
Marketed
Nizoral
Ketoconazole Patriot (ketoconazole)
Pityriasis Simplex Capillitii (Dandruff)
Patriot Pharmaceuticals LLC
0 catalysts
Phase 2
Norovirus [strains Norwalk GI.1 + Sydney GII.4] (bivalent) vaccine
Norovirus Infections
$VXRTVaxart, Inc.
0 catalysts
Phase 1
OCF-001
Vulvovaginal Candidiasis
Sano Chemicals Inc
0 catalysts
Preclinical
OCU-510
Seasonal Influenza
$OCGNOcugen, Inc.
0 catalysts
Preclinical
OCU-520
Coronavirus Disease 2019 (COVID-19)
$OCGNOcugen, Inc.
0 catalysts
Preclinical
OS-151
Tuberculosis
OncoSTING LLC
0 catalysts
Preclinical
Oximo
Genital Herpes
Oxymo Technologies Inc
0 catalysts
Preclinical
P-MAPA
Schistosomiasis
Farmabrasilis
0 catalysts